Physician Participation in Market Support Clinical Studies and Subsequent Prescribing Behavior

Journal of Pharmaceutical Marketing and Management

Volumn 15, Issue 4, 2003, Pages 3-16

  Glass, Harold E ^a,b  

^a UNIVERSITY OF THE SCIENCES   (United States)

^b UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

clinical investigators; Clinical trials; Phase IIIb; Phase IV; prescribing

Indexed keywords

EID: 84996237566     PISSN: 08837597     EISSN: 15408574     Source Type: Journal    
DOI: 10.3109/J058v15n04_02     Document Type: Article

References (11)

1. Coleman J, Katz E, Menzel H. The diffusion of an innovation among physi-cians. Sociometty. 1957; 20: 253 – 70.
2. McKinney WP, Schiedermayer DL, Lurie N, Simpson DE, Goodman JL, Rich EC. Attitudes of internal medicine faculty and residents toward professional interac-tions with pharmaceutical sales representatives. JAMA. 1990; 264: 1693 – 7.
3. Lichstein PR, Turner RC, O'Brien K. Impact of pharmaceutical company repre-sentatives on internal medicine residency programs. A survey of residency program di-rectors. Arch Intern Med. 1992; 152: 1009 – 13.
4. Wazanna A. Physicians and the pharmaceutical industry: Is a gift ever just a gift? JAMA. 2000; 283: 373 – 80.
5. Lexchin J. Interactions between physicians and the pharmaceutical industry: What does the literature say? CMAJ. 1993; 149: 1401 – 7.
6. Avorn J, Chen M, Hartley R. Scientific versus commercial sources of influence on the prescribing behavior of physicians. Am J Med. 1982; 73: 4 – 8.
7. Guldal D, Semin S. The influences of drug companies' advertising programs on physicians. Int J Health Serv. 2000; 30: 585 – 95.
8. Glass HE. Why investigators take part in clinical trials. Appl ClM Trials. 2000; (Jun): 46 – 54.
9. Hovde M, Seskin R. Selecting U.S. clinical investigators. Appl Clin Trials. 1997; 6(Feb): 34 – 42.
10. Denig P, Haaijer-Ruskamp FM, Wesseling H, Versluis A. Impact of clinical tri-als on the adoption of new drugs within a university hospital. Eur J Clin Pharmaco L 1991; 41: 325 – 8.
11. Jones MI, Greenfield SM, Jowett S, et al. Proton pump inhibitors: A study of GPs' prescribing. Fam Prac L 2001; 18: 333 – 8.